MSKCC Risk Stratification Model in RCC Updated to Include Genomic Information

The Memorial Sloan Kettering Cancer Center (MSKCC) risk stratification model in advanced renal cell carcinoma (RCC) currently used in clinical practice stratifies patients into risk groups of favorable, intermediate, and poor.12/28/2018

Source: Kidney Cancer Association - December 28, 2018 Category: Urology & Nephrology Source Type: news